Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.62 |
| ▸ | CA9 | Q16790 | 7/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | ALB | P02768 | 5/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.55 |
| ▸ | GLA | P06280 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7162196 | 0.99 | CA12 (0.64) | CA12CA9CA4ALBMAOB | |
| SCHEMBL984094 | 0.97 | CA12 (0.62) | CA12CA9CA4ALBMAOB | |
| SCHEMBL27456148 | 0.87 | CA12 (0.62) | CA12CA9CA4ALBMAOB | |
| SCHEMBL984092 | 0.84 | CA9 (0.62) | CA12CA9CA4ALBMAOB | |
| SCHEMBL2766697 | 0.81 | ALDH1A1 (0.67) | CA12CA9CA4ALBMAOB | |
| SCHEMBL1034943 | 0.80 | CA12 (0.72) | CA12CA9CA4ALBMAOB | |
| SCHEMBL29673209 | 0.80 | CA12 (0.72) | CA12CA9CA4ALBMAOB | |
| SCHEMBL19026763 | 0.79 | CA12 (0.70) | CA12CA9CA4ALBMAOB | |
| SCHEMBL10879803 | 0.78 | ALDH1A1 (0.67) | CA12CA9CA4ALBMAOB | |
| SCHEMBL24589798 | 0.78 | CA12 (0.68) | CA12CA9CA4ALBMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100038632-A1 | ELECTROLUMINESCENT DEVICE | OLED-T LIMITED (GB) | 2010-02-18 | — | — | US | claimed |
| US-20070254183-A1 | Electroluminescent materials and deivces | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | US | claimed |
| US-20070190357-A1 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2007-08-16 | — | — | US | claimed |
| EP-2984079-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2020-07-01 | — | — | EP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2018-11-08 | — | — | US | disclosed |
| EP-2232611-B1 | BARRIER COATED SUBSTRATE AND ELECTRO-OPTICAL DEVICE | MERCK PATENT GMBH (DE) | 2017-11-01 | — | — | EP | disclosed |
| US-9437828-B2 | Electroluminescent device using azomethine-lithium-complex as electron injection layer | MERCK PATENT GMBH (DE) | 2016-09-06 | — | — | US | disclosed |
| EP-2984079-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | Power Oleds Limited (GB) | 2016-02-17 | — | — | EP | disclosed |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| US-9221770-B2 | Compounds having electron transport properties, their preparation and use | MERCK PATENT GMBH (DE) | 2015-12-29 | — | — | US | disclosed |
| US-20060072053-A1 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2006-04-06 | — | — | US | disclosed |
| WO-2006024831-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | OLED-T LIMITED (GB) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006003405-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | OLED-T LIMITED (GB) | 2006-01-12 | — | — | WO | disclosed |
| EP-1585797-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | ELAM-T Limited (GB) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004058913-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | ELAM-T LIMITED (GB) | 2004-07-15 | — | — | WO | disclosed |
| EP-0281381-B1 | ELECTROLUMINESCENT DEVICE WITH MODIFIED THIN FILM LUMINESCENT ZONE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-07-15 | — | — | EP | disclosed |
| US-4933948-A | Inclusion compound of cyclodextrin and fluorescent dye | EASTMAN KODAK COMPANY (US) | 1990-06-12 | — | — | US | disclosed |
| EP-0281381-A2 | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-09-07 | — | — | EP | disclosed |
| US-4769292-A | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | CA12 3801/4885CA9 2290/4885CA4 1982/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | CA12 3801/4885CA9 2290/4885CA4 1982/4885 |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | CA12 3801/4885CA9 2290/4885CA4 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.